Navigation Links
Luminex Corporation Awarded $11 Million Contract by Defense Threat Reduction Agency (DTRA)
Date:8/9/2012

AUSTIN, Texas, Aug. 9, 2012 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) announced today it has been awarded a contract worth up to $11.6 million over three and a half years. The contract will fund development of a prototype instrument that is highly portable, field-deployable diagnostic tool capable of rapid detection of biothreat agents and patient response biomarkers indicative of systemic disease. This hand-held system will detect both protein and nucleic acid targets to aid diagnosis of Systemic Inflammatory Response Syndrome (SIRS), a consequence of blood infection in conventional combat, biowarfare and combat operations in developing and resource-limited areas.

(Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO)

Infection and disease caused by biowarfare agents carry the very real threat of catastrophic illness and death of military and civilian personnel.  The pathophysiology of candidate biowarfare microbes is varied and may involve multiple organ systems, but there are some common features associated with bloodstream infection that permit the development of a sensitive diagnostic test that not only identifies biowarfare pathogens but also can be use outside of an executed bioagent attack.

"Rapid response and informed decisions on therapeutic options are critical in managing biothreat agent exposure," said Amy Altman, Ph.D., vice president Luminex Biodefense. "The flexibility and scalability of our multiplexing technology allow for the measurement of RNA, DNA and proteins with the same system, aiding rapid and accurate diagnosis of these severe conditions.  Development of a field deployable device using our technology has the potential to provide significant advancement in biothreat detection."

"Lu
'/>"/>

SOURCE Luminex Corporation
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Luminex Corporation and University Hospital of Wales Collaborate During Olympic Games
2. Luminex Corporation Reports Second Quarter 2012 Results
3. Luminex Corporation Second Quarter Earnings Release Scheduled for July 30, 2012
4. Luminex Corporation Announces Agreement to Acquire GenturaDx
5. Luminex Corporation Reports First Quarter 2012 Results
6. American Pacific Corporation Commences Debt Refinancing
7. Omeros Corporation Reports Second Quarter 2012 Financial Results
8. Volcano Corporation Presentation At Canaccord Genuity Conference To Be Webcast
9. DURECT Corporation Announces Second Quarter 2012 Financial Results and Update of Programs
10. Volcano Corporation Reports 13 Percent Growth In Second Quarter Revenues; FFR Disposable Revenues Increase 38 Percent
11. HeartWare Completes Acquisition Of World Heart Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... 2013  Decision Resources, one of the world,s ... healthcare issues, finds that, for the treatment of ... European rheumatologists cite a therapy,s induction of remission ... their prescribing decisions. Over 60 percent and 70 ... the percentage of patients achieving remission at six ...
(Date:6/19/2013)... , June 19, 2013 BD Biosciences, a segment ... ), a leading global medical technology company, today announced the ... the latest in its line of high-performance research flow cytometers. ... high-performance multicolor analysis with the most compact footprint in its ... and a height of 30" (76.2 cm). Recognizing that space ...
(Date:6/19/2013)... , June 19, 2013 /PRNewswire-iReach/ -- ... a new specialty pharmaceutical company dedicated to ... innovative injectable and sustained release drug therapies ... medical needs, today announced the acquisition of ... Technology®) platform and associated product pipeline. Acquisition ...
Breaking Medicine Technology:U.S. and European Rheumatologists Agree That a Therapy's Induction of Remission is One of the Attributes That Most Influences Their Prescribing Decisions in Rheumatoid Arthritis 2New BD Biosciences Flow Cytometry Cell Analyzer Enables Complex Multicolor Experiments in Disease Research 2Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 2Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 3Belrose Pharma Acquires Enzon's Advanced Drug Formulation Technology and Clinical Assets as Foundation for Driving Development of More Effective Injectable and Sustained Release Therapies 4
... Unprecedented amount of research reflects depth and breadth of, collaboration with investigators ... ... highlight impact of Zometa(R), the leading IV, bisphosphonate, on relapse rate of patients ... oral once-daily continuous, inhibitor of mTOR, including first results of RECORD-1 study in ...
... identify the, lipid core (fatty) coronary plaques of interest ... ... 15 InfraReDx, Inc. today,announced that physicians at Beaumont Hospital ... System in a patient,undergoing a cardiac catheterization. This is the ...
Cached Medicine Technology:Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 2Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 3Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 4Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 5Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 6Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 7Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 8Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 9Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 10First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 2First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 3First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 4
(Date:6/20/2013)... 2013 Dr. Ramtin Kassir is ... Jersey and NYC and a top cosmetic ... his philosophy is to provide individualized care for a broad ... laser-lifts. The surgeon is partnering with the new and emerging ... Co for its specialized needs. , "We are partnering with ...
(Date:6/20/2013)... Footwear etc. is pleased to announce the relaunch of ... new styles and colors for the spring. This line includes ... in the U.S. The relaunch is expected to be incredibly ... MBT shoes feature a unique rocker sole bottom that emulates ... outstanding shock absorption, and helps produce improved posture. Customers have ...
(Date:6/20/2013)... (PRWEB) June 20, 2013 David Icke, the ... global TV and Radio station. , Fresh from the ... David Icke is getting ready to launch ‘The Peoples Voice’ ... This station is a fantastic opportunity for journalists to cover ... from all areas of the globe. , Because this ...
(Date:6/20/2013)... City, UT (PRWEB) June 20, 2013 ... assurance solution that guides users through a HIPAA Security ... The new website launched today extends the reach of ... of HIPAA Security Officers, HIPAA Privacy Officers, security professionals, ... security, privacy, consulting, measures, processes, policies and procedures. ...
(Date:6/19/2013)... Everyone is looking for ways to improve general health. Sublime ... It is called Skin Brushing . Skin Brushing can be ... - to improve health and skin quality. It is fun ... Skin Brushing improves general health because:, , it ... to drain toxins , it clears skins of dead ...
Breaking Medicine News(10 mins):Health News:Celebrity Plastic Surgeon Dr. Kassir Teams Up With X Factor Selling Systems to Enhance Patient Experience 2Health News:Footwear etc. Announces New MBT Shoes for Spring/Summer 2Health News:Modern Compliance Solutions Launches a New Web Site Promoting the Industry-Proven, Web-Based HIPAA One Security Solution 2Health News:A Fast and Fun Way to Better Skin Quality and Overall Health, says Sublime Beauty® 2
... ... approval of its biologics license application (BLA) for the first 15 monoclonal antibodies in its ... an exclusive agreement with the MED Alliance Group, Inc. (MAGI) to serve as its distributor ... ...
... DALLAS, Oct. 28 Parkland Health & Hospital ... limited English speaking patients by expanding its language ... Phones in patient rooms and other locations throughout ... from Language Line Services, the leading interpretation and ...
... Inc., a subsidiary of Eisai Inc., announced today that ... Ortho Biotech Inc. for development and commercialization of an ... solid tumors. , Under the terms of ... license for the development, manufacture and sale of the ...
... 28 /PRNewswire-Asia/ -- Winner Medical Group Inc.,(AMEX: WWIN ... and,the largest exporter by volume in the medical dressing ... (Shenzhen) Co., Ltd., or,"Winner Shenzhen", won a Contribution in ... The winner of the Contribution in ...
... Connectyx Technologies Holdings Group Inc. (Pink Sheets: CTYX), announced ... revolutionary tool for the management of medical, health and lifestyle ... internet based, data storage and transfer platform that allows a ... features secure storage and access to data from a variety ...
... LONDON, October 28 Parents looking to ... advised to buy,BornFree(TM), the world,s leading brand for baby ... (BPA), which is now available,across the UK. , ... BPA leach into food or beverages,stored in polycarbonate containers, ...
Cached Medicine News:Health News:Quotient Biodiagnostics Signs MED Alliance Group, Inc. as Exclusive Distributor in Midwest for Line of Transfusion Diagnostics 2Health News:Quotient Biodiagnostics Signs MED Alliance Group, Inc. as Exclusive Distributor in Midwest for Line of Transfusion Diagnostics 3Health News:Parkland Health & Hospital System Expands Language Access with Language Line(R) Phones in Every Patient Room 2Health News:Parkland Health & Hospital System Expands Language Access with Language Line(R) Phones in Every Patient Room 3Health News:Morphotek(R), Inc. Announces a Licensing Deal With Centocor Ortho Biotech Inc. for Exclusive Development and Commercialization Rights for a Therapeutic Monoclonal Antibody 2Health News:Winner Medical's Subsidiary Won Contribution in Chinese Nonwovens and Industrial Textiles Industry Award 2Health News:Winner Medical's Subsidiary Won Contribution in Chinese Nonwovens and Industrial Textiles Industry Award 3Health News:Connectyx Announces the MedFlash Personal Health Manager 2Health News:Connectyx Announces the MedFlash Personal Health Manager 3Health News:BornFree Baby Bottles Borne Into Britain 2
... Sports Medicine™ POLYSORB™ Soft Tissue Anchor 3 mm ... soft tissue to bone using sutures. The resorbable ... in the bone, and is used to attach ... a resorbable copolymer, derived from glycolide and lactide ...
... USS Sports Medicine™ POLYSORB™ Soft Tissue Anchor 2 ... attach soft tissue to bone using sutures. The ... hole in the bone, and is used to ... made of a resorbable copolymer, derived from glycolide ...
Sutureless Harpoon Tip...
... type of anchor is generally utilized when a ... into the bone. Unlike other anchors that require ... does not have that limitation. The only instrument ... a mallet. The 4.4mm Stainless Steel Anchor is ...
Medicine Products: